| 000 | 01491 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250512051335.0 | ||
| 264 | 0 | _c19880802 | |
| 008 | 198808s 0 0 eng d | ||
| 022 | _a0190-9622 | ||
| 024 | 7 |
_a10.1016/s0190-9622(88)70130-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aIkeda, S | |
| 245 | 0 | 0 |
_aProtease inhibitor therapy for recessive dystrophic epidermolysis bullosa. In vitro effect and clinical trial with camostat mesylate. _h[electronic resource] |
| 260 |
_bJournal of the American Academy of Dermatology _cJun 1988 |
||
| 300 |
_a1246-52 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdministration, Topical |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aBlister _xphysiopathology |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 |
_aEpidermolysis Bullosa _xdrug therapy |
| 650 | 0 | 4 | _aEsters |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGabexate _xanalogs & derivatives |
| 650 | 0 | 4 | _aGenes, Recessive |
| 650 | 0 | 4 |
_aGuanidines _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aOrgan Culture Techniques |
| 650 | 0 | 4 |
_aProtease Inhibitors _xadministration & dosage |
| 650 | 0 | 4 |
_aSkin _xdrug effects |
| 700 | 1 | _aManabe, M | |
| 700 | 1 | _aMuramatsu, T | |
| 700 | 1 | _aTakamori, K | |
| 700 | 1 | _aOgawa, H | |
| 773 | 0 |
_tJournal of the American Academy of Dermatology _gvol. 18 _gno. 6 _gp. 1246-52 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0190-9622(88)70130-9 _zAvailable from publisher's website |
| 999 |
_c3390772 _d3390772 |
||